Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Fresenius Kabi Oncology

Sector: Healthcare | Industry: Drugs & Pharma
R 132.50 0.45  | 0.34% 20.45% 115.14 2,254.93
NSE Price: Jan 02, 2014 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Jan 02, 2014 132.50 0.45 0.34% 132.00 132.05 175,153 132.00 - 132.75
BSE Jan 02, 2014 132.45 0.35 0.27% 132.00 132.10 91,518 132.00 - 132.60
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 207,686 P/B: 3.60 NSE Code: FKONCO
52-Week Range: R 94.35 - 154.00 Dividend Yield: 0.00% BSE Code: 532545
TTM EPS: R 1.15 Book Value: R 36.78 Face Value: R 1
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 12.73 14.87 3.36
Net Profit 910.66 28.56 -24.64
EPS 910.66 28.56 -25.74
Book Value 4.52 -4.27 -8.75
Average
Operating Margin 22.64 12.74 2.48
Net Margin 2.68 -4.20 -13.95
Return on Networth 4.37 -4.45 -12.07
Return on Investment 6.80 1.00 -5.00
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -11.95 -58.71 -9.20
Operating Profit -11.90 -155.86 -370.85
Net Profit -42.04 -231.58 -720.15
EPS -14.26 -205.84 -5,273.26
TTM
Revenue -23.09 -36.09 -32.77
Operating Profit -167.80 -128.58 -128.10
Net Profit -18,570.98 -223.71 -238.21
EPS -1,343.33 -213.45 -205.42
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Fresenius Kabi Oncology 2,254.93 400.91 -111.38 -21.97 4.37 3.60 115.14
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Aug 11, 2008 AC Burman-HUF  Sell Off Market 2,500 61.95 1.55
Aug 11, 2008 Aditya Burman  Sell Off Market 2,500 61.95 1.55
Aug 11, 2008 Aeee Enterprises  Sell Off Market 18,189,819 61.95 11,268.59
Aug 11, 2008 Amit Burman  Sell Off Market 100 61.95 0.06
Aug 11, 2008 Anand Burman  Sell Off Market 18,500 61.95 11.46
Fund Houses invested in the stock
Fund Dec-13 Sep-13 Jun-13 Mar-13 Dec-12
IDFC Mutual Fund 0.205 - - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Fresenius Kabi Oncology Ltd.

Address: B - 310, Som Datt Chambers - I, Bhikaji Cama Place, New Delhi, Delhi - 110066 | Phone: 011-26105570 | Fax: 011-26195965

Email: [email protected]

Website: www.fresenius-kabi-oncology.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: Narang Tower 44, Community Centre,Naraina Industrial Area Phase - 1,New Delhi - 110 028, Narang Tower 44, Community Centre, Naraina Industrial Area, Phase - 1

Email: [email protected]

Essential checks
Altman Z-Score
2.86
Piotroski F-Score
9
Modified C-Score
1